LEWISVILLE, Texas--(BUSINESS WIRE)--Jul. 26, 2018--
Orthofix International N.V. (NASDAQ:OFIX), a global medical device
company focused on musculoskeletal products and therapies, today
announced that it plans to release financial results for the second
quarter 2018 after market close on Monday, August 6, 2018. Brad Mason,
Chief Executive Officer, and Doug Rice, Chief Financial Officer, will
host a conference call and webcast to review the Company’s results at
4:30 p.m. ET the same day.
Interested parties may access the conference call by dialing (844)
809-1992 in the U.S. and (612) 979-9886 outside the U.S., and
referencing the conference ID 5556977. A replay of the call will be
available for two weeks by dialing (855) 859-2056 in the U.S. and (404)
537-3406 outside the U.S., and entering the conference ID 5556977. A
webcast of the conference call may be accessed by going to the Company's
website www.orthofix.com
by clicking on the Investors link and then the Events and Presentations
page.
About Orthofix:
Orthofix International N.V. is a global medical device company focused
on musculoskeletal healing products and value-added services. The
Company’s mission is to improve patients' lives by providing superior
reconstruction and regenerative musculoskeletal solutions to physicians
worldwide. Headquartered in Lewisville, Texas, the Company has four
strategic business units: BioStim, Extremity Fixation, Spine Fixation,
and Biologics. Orthofix products are widely distributed via the
Company's sales representatives and distributors. For more information,
please visit www.orthofix.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180726005952/en/
Source: Orthofix International N.V.
Orthofix International N.V.
Investor Contact:
Mark
Quick, 214-937-2924
markquick@orthofix.com
or
Media
Contact:
Denise Landry, 214-937-2529
deniselandry@orthofix.com